MSMichael Schrader

Michael Schrader

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael Schrader has a total of 179 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ACBD5 as a Master Tether of Peroxisomes: Integrating Organelle Contact Sites, Lipid Sensing, and Cellular Homeostasis

    by Michael Schrader, Peter K. Kim, Ruth E. Carmichael

    Acyl-CoA-binding domain-containing proteins (ACBDs) constitute a large and diverse multigene family involved in cellular lipid metabolism. Among them, the tail-anchored peroxisomal membrane protein ACBD5 has emerged as a key component of peroxisome–endoplasmic reticulum (ER) contact sites through its interaction with VAMP-associated proteins (VAPs). More recently, ACBD5 has also been implicated in peroxisome–mitochondria tethering under conditions of oxidative stress. Although initially characterized as a lipid-binding peroxisomal membrane protein, ACBD5 is increasingly recognized as a central mediator of inter-organelle cooperation. Here, we propose an expanded view of ACBD5 function, suggesting that it acts as a peroxisomal “master tether” that integrates intracellular organisation with metabolic and homeostatic regulation. By linking lipid sensing and metabolism to the formation and regulation of membrane contact sites, ACBD5 may serve as a key organizer of peroxisomal interactions within the cellular organelle network. We discuss the role of peroxisomes as interconnected hubs of cellular cooperation, examine the functions of ACBD5 at peroxisome–ER contact sites and beyond, highlight its relevance to human disease, and present a conceptual framework for understanding ACBD5 as a peroxisomal master tether.

  • Open Access

    Visualisation of peroxisomes: a journey through seven decades

    by Xinyu Tang, Markus Islinger, Michael Schrader

    Peroxisomes are ubiquitous, oxidative organelles in eukaryotes with conserved functions in cellular lipid metabolism and redox balance. They are now recognised as key metabolic organelles of medical importance, with contributions to antiviral signalling, pathogen defence, innate immunity, cancer and neurodegeneration. Our current knowledge of peroxisomes and the molecular understanding of their diverse functions and roles in disease have been achieved through a combination of biochemical and morphological studies. This review provides a comprehensive overview of the morphological techniques and approaches developed over the past 70 years to specifically label, identify and visualise peroxisomes in mammals, yeast and plants. We discuss the historical milestones that led to the first visualisation of peroxisomes in these organisms and trace the evolution of imaging strategies from early cytochemical and electron microscopy methods to modern fluorescence-based and high-resolution techniques. By highlighting the contribution of these approaches to advances in peroxisome biology, this review aims to place current peroxisome visualisation methods in a historical and methodological context.


  • Obituary—Prof. Dr. H. Dariush Fahimi

    by Michael Schrader, Markus Islinger, Alfred Voelkl

  • Top Cited Papers

    ROS transfer at peroxisome-mitochondria contact regulates mitochondrial redox

    by Laura F. DiGiovanni, Prabhsimran K. Khroud, Ruth E. Carmichael, Tina A. Schrader, Shivneet K. Gill, Kyla Germain, Robert Y. Jomphe, Christoph Wiesinger, Maxime Boutry, Maki Kamoshita, et al.

    Maintenance of mitochondrial redox homeostasis is of fundamental importance to cellular health. Mitochondria harbor a host of intrinsic antioxidant defenses, but the contribution of extrinsic, nonmitochondrial antioxidant mechanisms is less well understood. We found a direct role for peroxisomes in maintaining mitochondrial redox homeostasis through contact-mediated reactive oxygen species (ROS) transfer. We found that ACBD5 and PTPIP51 form a contact between peroxisomes and mitochondria. The percentage of these contacts increased during mitochondrial oxidative stress and helped to maintain mitochondrial health through the transfer of mitochondrial ROS to the peroxisome lumen. Our findings reveal a multiorganelle layer of mitochondrial antioxidant defense—suggesting a direct mechanism by which peroxisomes contribute to mitochondrial health—and broaden the scope of known membrane contact site functions.


  • Open Access

    The neurological pathology of peroxisomal ACBD5 deficiency – lessons from patients and mouse models

    by Michael L. Dawes, Jim P. Haberlander, Markus Islinger, Michael Schrader

    The absence or dysfunction of the peroxisomal membrane protein Acyl-CoA Binding Domain-Containing Protein 5 (ACBD5) is the cause of the most recently discovered peroxisomal disorder “Retinal Dystrophy with Leukodystrophy” (RDLKD). ACBD5 is a tail-anchored protein, anchored by its C-terminus into the peroxisomal membrane; hence, the bulk of its amino acid sequence faces the cytosol. With respect to ACBD5’s molecular functions, RDLKD is unique since it is not only an accessory protein for the import of very-long-chain fatty acids (VLCFAs) into peroxisomes but also the first identified peroxisomal tethering protein facilitating membrane contacts with the endoplasmic reticulum (ER). Consequently, RDLKD is neither a peroxisomal biogenesis disorder nor single enzyme deficiency, since a deficiency in ACBD5 likely affects several aspects of peroxisomal function including VLCFA degradation, ether lipid synthesis, docosahexaenoic acid synthesis but also the transfer of membrane lipids from the ER to peroxisomes. Hence, RDLKD appears to be a multifactorial disorder leading to a mosaic pathology, combining symptoms caused by the disruption of several pathways. In this review, we will highlight recent findings obtained from case reports of RDLKD patients as well as insights from ACBD5-deficient mouse models to better understand its complex retinal and brain pathology. Moreover, we will discuss the possible contribution of the different dysregulated metabolites in the neurological pathogenesis of this latest peroxisomal disorder.


  • Integrated proteome and lipidome analyses place OCIAD1 at the mitochondria–peroxisome intersection balancing lipid metabolism

    by Vanessa Linke, Mateusz Chodkowski, Kacper Kaszuba, Mariusz Radkiewicz, Tina A. Schrader, Hirak Das, Vikas Rana, Dorota Stadnik, Michał Dadlez, Bettina Warscheid, et al.

    Ovarian cancer immunoreactive antigen domain-containing 1 (OCIAD1) is a membrane protein largely localized to mitochondria; however, its function in health or disease is not well understood. To comprehensively characterize the molecular changes upon lack of OCIAD1, we used mass spectrometry to study the mitochondrial and cellular proteome and lipidome. We show that there is extensive lipidome rearrangement in OCIAD1 knockout (KO) cells, characterized by two main phenotypes of decreased levels of ether phospholipids and decreased levels of phospholipids with an odd number of carbons. The lipidomic changes suggest alterations in peroxisomal lipid metabolism. At the same time, proteins responsible for mitochondrial fatty acid β-oxidation are significantly increased. Together with a global loss in peroxisomal proteins, aberrant peroxisomal morphology, and a meta-analysis of proximity labeling data, this gives a function to the previously observed partial localization of OCIAD1 to peroxisomes. We suggest a role for OCIAD1 in balancing mitochondrial and peroxisomal lipid metabolism, and a direct impact on the key enzymes FAR1 and ABCD3.


  • Open Access

    Modelling Peroxisomal Disorders in Zebrafish

    by Chenxing S. Jiang, Michael Schrader

    Peroxisomes are ubiquitous, dynamic, oxidative organelles with key functions in cellular lipid metabolism and redox homeostasis. They have been linked to healthy ageing, neurodegeneration, cancer, the combat of pathogens and viruses, and infection and immune responses. Their biogenesis relies on several peroxins (encoded by PEX genes), which mediate matrix protein import, membrane assembly, and peroxisome multiplication. Defects in peroxins or peroxisomal enzymes can result in severe disorders, including developmental and neurological abnormalities. The drive to understand the role of peroxisomes in human health and disease, as well as their functions in tissues and organs or during development, has led to the establishment of vertebrate models. The zebrafish (Danio rerio) has become an attractive vertebrate model organism to investigate peroxisomal functions. Here, we provide an overview of the visualisation of peroxisomes in zebrafish, as well as the peroxisomal metabolic functions and peroxisomal protein inventory in comparison to human peroxisomes. We then present zebrafish models which have been established to investigate peroxisomal disorders. These include model zebrafish for peroxisome biogenesis disorders/Zellweger Spectrum disorders, and single enzyme deficiencies, particularly adrenoleukodystrophy and fatty acid beta-oxidation abnormalities. Finally, we highlight zebrafish models for deficiencies of dually targeted peroxisomal/mitochondrial proteins. Advantages for the investigation of peroxisomes during development and approaches to the application of zebrafish models for drug screening are discussed.


  • Open Access

    Seventy years of peroxisome research: current advances and future perspectives

    by Ruth E. Carmichael, Silke Oeljeklaus, Luis D. Cruz-Zaragoza, Rechal Kumar, Chloe Bolton, Markus Islinger, Markus Kunze, Jorgaq Pata, Celien Lismont, Beatriz S. C. Silva, et al.


  • Open Access

    New insights into the functions of ACBD4/5-like proteins using a combined phylogenetic and experimental approach across model organisms

    by Suzan Kors, Martin Schuster, Daniel C. Maddison, Sreedhar Kilaru, Tina A. Schrader, Joseph L. Costello, Markus Islinger, Gaynor A. Smith, Michael Schrader


  • Open Access

    New insights into the functions of ACBD4/5-like proteins using a combined phylogenetic and experimental approach across model organisms

    by Suzan Kors, Martin Schuster, Daniel C. Maddison, Sreedhar Kilaru, Tina A. Schrader, Joseph L. Costello, Markus Islinger, Gaynor A. Smith, Michael Schrader

    Acyl-CoA binding domain-containing proteins (ACBDs) perform diverse but often uncharacterised functions linked to cellular lipid metabolism. Human ACBD4 and ACBD5 are closely related peroxisomal membrane proteins, involved in tethering of peroxisomes to the ER and capturing fatty acids for peroxisomal β-oxidation. ACBD5 deficiency causes neurological abnormalities including ataxia and white matter disease. Peroxisome-ER contacts depend on an ACBD4/5-FFAT motif, which interacts with ER-resident VAP proteins. As ACBD4/5-like proteins are present in most fungi and all animals, we combined phylogenetic analyses with experimental approaches to improve understanding of their evolution and functions. Notably, all vertebrates exhibit gene sequences for both ACBD4 and ACBD5, while invertebrates and fungi possess only a single ACBD4/5-like protein. Our analyses revealed alterations in domain structure and FFAT sequences, which help understanding functional diversification of ACBD4/5-like proteins. We show that the Drosophila melanogaster ACBD4/5-like protein possesses a functional FFAT motif to tether peroxisomes to the ER via Dm_Vap33. Depletion of Dm_Acbd4/5 caused peroxisome redistribution in wing neurons and reduced life expectancy. In contrast, the ACBD4/5-like protein of the filamentous fungus Ustilago maydis lacks a FFAT motif and does not interact with Um_Vap33. Loss of Um_Acbd4/5 resulted in an accumulation of peroxisomes and early endosomes at the hyphal tip. Moreover, lipid droplet numbers increased and mitochondrial membrane potential declined, implying altered lipid homeostasis. Our findings reveal differences between tethering and metabolic functions of ACBD4/5-like proteins across evolution, improving our understanding of ACBD4/5 function in health and disease. The need for a unifying nomenclature for ACBD proteins is discussed.